• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表现为皮质下分水岭梗死的慢性淋巴细胞白血病

Chronic Lymphocytic Leukemia Presenting as a Subcortical Watershed Infarct.

作者信息

Gupta Mridul, Singh Divita, Lee Patrick, Kadiyam Sandhya

机构信息

Internal Medicine, Monmouth Medical Center, Long Branch, New Jersey, USA.

Ambulatory Care Pharmacy Resident, University of Florida, Gainesville, Florida, USA.

出版信息

Case Rep Hematol. 2019 Jan 9;2019:2089359. doi: 10.1155/2019/2089359. eCollection 2019.

DOI:10.1155/2019/2089359
PMID:30729050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6343168/
Abstract

Internal watershed infarcts (WI) involve white matter between deep and superficial arterial systems of middle cerebral artery. These infarcts are considered to be either from low blood flow or microembolism. Anemia is an extremely rare cause of watershed infarcts. Very few cases of hemolytic anemia causing watershed cerebral infarcts have been reported. Chronic lymphocytic leukemia (CLL) is frequently complicated with secondary autoimmune cytopenia such as autoimmune hemolytic anemia (AIHA), immune thrombocytopenia (ITP), and pure red cell aplasia. AIHA is present in about 7-10% of patients with CLL. AIHA from CLL presenting as WI is an extremely rare phenomenon with no previously published case reports to the best of our knowledge.

摘要

脑内分水岭梗死(WI)累及大脑中动脉深、浅动脉系统之间的白质。这些梗死被认为是由低血流或微栓塞引起的。贫血是分水岭梗死极为罕见的病因。很少有溶血性贫血导致分水岭脑梗死的病例报道。慢性淋巴细胞白血病(CLL)常并发继发性自身免疫性血细胞减少,如自身免疫性溶血性贫血(AIHA)、免疫性血小板减少症(ITP)和纯红细胞再生障碍。约7%-10%的CLL患者存在AIHA。据我们所知,CLL所致AIHA表现为WI是一种极其罕见的现象,此前尚无病例报告发表。

相似文献

1
Chronic Lymphocytic Leukemia Presenting as a Subcortical Watershed Infarct.表现为皮质下分水岭梗死的慢性淋巴细胞白血病
Case Rep Hematol. 2019 Jan 9;2019:2089359. doi: 10.1155/2019/2089359. eCollection 2019.
2
Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.自身免疫性血细胞减少并不能预测慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的不良预后。
Am J Hematol. 2003 Sep;74(1):1-8. doi: 10.1002/ajh.10369.
3
Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.自身免疫性疾病与慢性淋巴细胞白血病:自身免疫性溶血性贫血、纯红细胞再生障碍性贫血及自身免疫性血小板减少症。
Semin Oncol. 1998 Feb;25(1):80-97.
4
Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.慢性淋巴细胞白血病(CLL)中细胞减少症的发病机制、流行率和预后意义:来自 1518 例 CLL 国家数据库的 213 例患者的回顾性对比研究。
Ann Hematol. 2013 May;92(5):661-7. doi: 10.1007/s00277-012-1663-3. Epub 2012 Dec 29.
5
Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.慢性淋巴细胞白血病中的自身免疫性血细胞减少症:简要综述及治疗建议
Expert Rev Hematol. 2018 Aug;11(8):613-624. doi: 10.1080/17474086.2018.1489720. Epub 2018 Jul 14.
6
Immune-mediated hemolytic anemia and thrombocytopenia in clonal B-cell disorders: a review.克隆性B细胞疾病中的免疫介导性溶血性贫血和血小板减少症:综述
Clin Adv Hematol Oncol. 2018 Oct;16(10):670-676.
7
Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.利妥昔单抗-环磷酰胺-地塞米松联合治疗与慢性淋巴细胞白血病相关的自身免疫性血细胞减少症。
Leukemia. 2011 Mar;25(3):473-8. doi: 10.1038/leu.2010.278. Epub 2010 Dec 3.
8
Autoimmune cytopenias in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的自身免疫性血细胞减少症。
Am J Hematol. 2014 Nov;89(11):1055-62. doi: 10.1002/ajh.23785. Epub 2014 Jul 7.
9
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects.慢性淋巴细胞白血病中的自身免疫性血细胞减少症:聚焦分子层面
Front Oncol. 2020 Jan 10;9:1435. doi: 10.3389/fonc.2019.01435. eCollection 2019.
10
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.利妥昔单抗治疗慢性淋巴细胞白血病相关的自身免疫性溶血性贫血。
Am J Hematol. 2006 Aug;81(8):598-602. doi: 10.1002/ajh.20665.

本文引用的文献

1
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.iwCLL 指南:用于 CLL 的诊断、治疗指征、疗效评估和支持性管理。
Blood. 2018 Jun 21;131(25):2745-2760. doi: 10.1182/blood-2017-09-806398. Epub 2018 Mar 14.
2
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
3
The Pathophysiology of Watershed Infarction: A Three-Dimensional Time-of-Flight Magnetic Resonance Angiography Study.
分水岭梗死的病理生理学:一项三维时间飞跃磁共振血管造影研究
J Stroke Cerebrovasc Dis. 2017 Sep;26(9):1966-1973. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.016. Epub 2017 Jul 8.
4
Treatment of chronic lymphocytic leukemia in older adults.老年慢性淋巴细胞白血病的治疗
J Geriatr Oncol. 2017 Sep;8(5):315-319. doi: 10.1016/j.jgo.2017.04.004. Epub 2017 May 6.
5
A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病中自身免疫性血细胞减少症的简要综述
Curr Hematol Malig Rep. 2017 Feb;12(1):29-38. doi: 10.1007/s11899-017-0366-1.
6
Secondary autoimmune cytopenias in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的继发性自身免疫性血细胞减少症
Semin Oncol. 2016 Apr;43(2):300-10. doi: 10.1053/j.seminoncol.2016.02.011. Epub 2016 Feb 8.
7
Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib.接受依鲁替尼治疗的慢性淋巴细胞白血病患者的自身免疫性血细胞减少症。
Haematologica. 2016 Jun;101(6):e254-8. doi: 10.3324/haematol.2015.138289. Epub 2016 Mar 24.
8
Etiologic Subtypes of Watershed Infarcts.分水岭梗死的病因亚型。
J Stroke Cerebrovasc Dis. 2015 Nov;24(11):2478-83. doi: 10.1016/j.jstrokecerebrovasdis.2015.06.002. Epub 2015 Sep 12.
9
Ibrutinib is an effective treatment of autoimmune haemolytic anaemia in chronic lymphocytic leukaemia.依鲁替尼是治疗慢性淋巴细胞白血病自身免疫性溶血性贫血的有效药物。
Br J Haematol. 2015 Sep;170(5):734-6. doi: 10.1111/bjh.13328. Epub 2015 Feb 25.
10
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).苯达莫司汀和利妥昔单抗联合治疗慢性淋巴细胞白血病相关自身免疫性溶血性贫血:法国 CLL 协作组(GCFLLC/MW 和 GOELAMS)的一项多中心回顾性研究。
Am J Hematol. 2015 Mar;90(3):204-7. doi: 10.1002/ajh.23909. Epub 2015 Jan 16.